Stellate Ganglion Block for Post-acute Sequelae of SARS-CoV-2 Infection With Coexisting Post-traumatic Stress Disorder, Anxiety, and Chronic Pain: A Case Report.

Stellate Ganglion Block for Post-acute Sequelae of SARS-CoV-2 Infection With Coexisting Post-traumatic Stress Disorder, Anxiety, and Chronic Pain: A Case Report.

Publication date: Jul 01, 2026

Post-acute sequelae of SARS-CoV-2 infection (PASC), commonly referred to as long COVID, is characterized by persistent symptoms, including fatigue, cognitive dysfunction, pain, and neuropsychiatric complaints, that can impair daily functioning. Proposed mechanisms are heterogeneous and may include autonomic dysregulation in a subset of patients. Stellate ganglion block (SGB) is a cervical sympathetic block used to treat symptoms of post-traumatic stress disorder (PTSD), anxiety, and, more recently, PASC. A 58-year-old man with a history of attention-deficit/hyperactivity disorder, generalized anxiety disorder, obsessive-compulsive disorder, autism spectrum disorder, PTSD, and chronic musculoskeletal pain developed persistent post-COVID symptoms following infection in March 2020, including brain fog, slowed information processing, word-finding difficulty, worsening anxiety, impaired balance, and reduced hand-eye coordination that significantly impaired occupational functioning as a chef. In January 2023, sequential left- and right-sided SGBs one week apart were performed to address cognitive dysfunction, fatigue, pain, and anxiety. Follow-up documentation described marked improvement in anxiety, frustration tolerance, and cognition lasting approximately six months. Repeat right-sided SGBs were performed in December 2024 and September 2025 for recurrence of symptoms and were again associated with symptomatic improvement. This is the first case demonstrating both longitudinal and reproducible functional improvement in cognitive symptoms, anxiety, and pain following serial SGBs in a patient with PASC complicated by psychiatric comorbidity and chronic pain. Although emerging observational literature suggests potential benefit of SGB in selected patients with PASC, prospective controlled studies are required to determine efficacy, mechanisms, and long-term outcomes.

Open Access PDF

Concepts Keywords
anxiety
dysautonomia
long covid
pasc
ptsd
stellate ganglion block

Semantics

Type Source Name
disease MESH Post-acute Sequelae of SARS-CoV-2 Infection
disease MESH Post-traumatic Stress Disorder
disease MESH Anxiety
disease MESH Chronic Pain
disease MESH fatigue
disease MESH cognitive dysfunction
disease MESH pain
disease MESH autism spectrum disorder
disease MESH PTSD
disease MESH musculoskeletal pain
disease MESH infection
disease MESH brain fog
drug DRUGBANK Isoxaflutole
disease MESH SGBs
disease MESH recurrence
disease MESH cognitive symptoms
pathway REACTOME Reproduction
disease MESH SARS CoV 2 Infection
disease MESH attention deficit hyperactivity disorder
disease MESH generalized anxiety disorder
disease MESH obsessive compulsive disorder
disease MESH dysautonomia
disease MESH inflammation
disease MESH injury
disease MESH syndromes
disease MESH included
disease MESH shoulder pain
disease MESH hyperlipidemia
disease MESH obstructive sleep apnea
disease MESH nephrolithiasis
disease MESH vitamin deficiency
drug DRUGBANK Amphetamine
drug DRUGBANK Dextroamphetamine
drug DRUGBANK Hydroxyzine
drug DRUGBANK Escitalopram
disease MESH anosmia
disease MESH ageusia
disease MESH fever
drug DRUGBANK Lidocaine
disease MESH paresthesia
disease MESH Head pain

Original Article

(Visited 12 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *